Aonong Group(SH:603363) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-04-11 23:49Core Viewpoint - The company, Fujian Aonong Biological Technology Group Co., Ltd., expects to achieve a net profit of between 200 million to 300 million yuan in the first quarter of 2025, marking a significant turnaround from losses in the previous year [2][4]. Group 1: Performance Forecast - The company anticipates a net profit attributable to shareholders of the parent company between 200 million to 300 million yuan for Q1 2025, an increase of 492.02 million to 592.02 million yuan compared to the same period last year, indicating a turnaround from losses [2][4]. - The expected net profit after deducting non-recurring gains and losses is projected to be between -35 million to -45 million yuan, which represents a reduction in losses of 318.37 million to 328.37 million yuan compared to the previous year [2][4]. Group 2: Previous Year’s Performance - In the same period last year, the company reported a total loss of 377.90 million yuan, with a net loss attributable to shareholders of the parent company of 292.02 million yuan [6]. - The net profit after deducting non-recurring gains and losses was -363.37 million yuan, with a loss per share of -0.34 yuan [6][7]. Group 3: Reasons for Performance Improvement - The company has undergone bankruptcy restructuring, which has allowed it to divest idle assets, reduce operational burdens, and significantly lower debt and interest expenses [8]. - The price of live pigs has increased compared to the same period last year, while the company's breeding costs have decreased significantly, leading to profitability in the breeding segment [8]. - The company recognized some restructuring gains during the reporting period, although depreciation and amortization for units awaiting resumption of production have had a negative impact on profits [8][9].